Chiappetta C, Della Rocca C, Di Cristofano C
Int J Mol Sci. 2025; 25(24.
PMID: 39769419
PMC: 11728052.
DOI: 10.3390/ijms252413657.
Tsai C, Wang C, Chang H, Chang P, Chang C, Chu T
Biomedicines. 2025; 12(12.
PMID: 39767566
PMC: 11726849.
DOI: 10.3390/biomedicines12122659.
Markovic L, Bukovac A, Varosanec A, Jakovcevic A, Tomas D, Sonicki Z
Sci Rep. 2024; 14(1):31725.
PMID: 39738380
PMC: 11685868.
DOI: 10.1038/s41598-024-82044-z.
Li C, Zhang L, Zhang J, Jiao J, Hua G, Wang Y
BMC Med. 2024; 22(1):604.
PMID: 39736662
PMC: 11686879.
DOI: 10.1186/s12916-024-03827-9.
Zhang X, You W, Wang Y, Dejenie R, Wang C, Huang Y
Front Immunol. 2024; 15:1499700.
PMID: 39620227
PMC: 11604707.
DOI: 10.3389/fimmu.2024.1499700.
Mutational analysis of the gene in patients with unilateral retinoblastoma.
Yousef Y, Mohammad M, Baqain L, Al-Hussaini M, Abu Shanap M, Halalsheh H
Front Med (Lausanne). 2024; 11:1406215.
PMID: 39234041
PMC: 11371786.
DOI: 10.3389/fmed.2024.1406215.
Retinoblastoma: An update on genetic origin, classification, conventional to next-generation treatment strategies.
Pareek A, Kumar D, Pareek A, Gupta M, Jeandet P, Ratan Y
Heliyon. 2024; 10(12):e32844.
PMID: 38975183
PMC: 11226919.
DOI: 10.1016/j.heliyon.2024.e32844.
Retinoblastoma in the Southern Philippines: Clinical Outcomes of Retinoblastoma Patients in a Davao Tertiary Hospital.
Malabanan-Cabebe C, Santos-Gonzales M, Te A, Tan R, Gonzales-Sy J
Acta Med Philipp. 2024; 58(6):45-51.
PMID: 38846169
PMC: 11151136.
DOI: 10.47895/amp.vi0.6754.
The evolvement of breast cancer therapies: What we have done and where all these head off.
Nurlaila I, Pambudi S
Saudi Med J. 2024; 45(4):331-340.
PMID: 38657992
PMC: 11147575.
DOI: 10.15537/smj.2024.45.4.20230492.
The Impact of Tumor Laterality (Unilateral vs. Bilateral) on Presentation and Management Outcome in Patients with Retinoblastoma.
Mohammad M, Mehyar M, Halalsheh H, Shehada R, Al Adawi O, Khzouz J
J Clin Med. 2024; 13(7).
PMID: 38610910
PMC: 11012679.
DOI: 10.3390/jcm13072146.
Prox1 Suppresses Proliferation and Drug Resistance of Retinoblastoma Cells via Targeting Notch1.
Zhang H, Li N, Dong L, Ma H, Yang M
Curr Med Sci. 2024; 44(1):223-231.
PMID: 38277016
DOI: 10.1007/s11596-023-2803-9.
Clinical and Histopathologic Predictors of Survival Among Children With Retinoblastoma From Two Tertiary Health Facilities in Uganda.
Atwine R, Laffita D, Birungi A, Kiconco R, Waddell K
Cureus. 2024; 15(12):e50605.
PMID: 38226099
PMC: 10788691.
DOI: 10.7759/cureus.50605.
RB1 screening of retinoblastoma patients in Sri Lanka using targeted next generation sequencing (NGS) and gene ratio analysis copy enumeration PCR (GRACE-PCR).
Kugalingam N, Silva D, Abeysekera H, Nanayakkara S, Tirimanne S, Ranaweera D
BMC Med Genomics. 2023; 16(1):279.
PMID: 37932687
PMC: 10626775.
DOI: 10.1186/s12920-023-01721-6.
Pharmacological induction of translational readthrough of nonsense mutations in the retinoblastoma (RB1) gene.
Palomar-Siles M, Yurevych V, Bykov V, Wiman K
PLoS One. 2023; 18(11):e0292468.
PMID: 37917619
PMC: 10621805.
DOI: 10.1371/journal.pone.0292468.
RB1 gene mutations and genetic spectrum in retinoblastoma cases.
Odemis D, Kebudi R, Bayramova J, Erciyas S, Kuru Turkcan G, Tuncer S
Medicine (Baltimore). 2023; 102(36):e35068.
PMID: 37682130
PMC: 10489529.
DOI: 10.1097/MD.0000000000035068.
Landscape of Genetic Mutations in Appendiceal Cancers.
Constantin M, Matanie C, Petrescu L, Bolocan A, Andronic O, Bleotu C
Cancers (Basel). 2023; 15(14).
PMID: 37509254
PMC: 10377024.
DOI: 10.3390/cancers15143591.
Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon.
OBrien T, Potter A, Driscoll C, Goh G, Letaw J, McCabe S
Am J Hum Genet. 2023; 110(8):1249-1265.
PMID: 37506692
PMC: 10432140.
DOI: 10.1016/j.ajhg.2023.06.014.
Epidemiological aspect of retinoblastoma in the world: a review of recent advance studies.
Koochakzadeh L, Yekta A, Hashemi H, Pakzad R, Heydarian S, Khabazkhoob M
Int J Ophthalmol. 2023; 16(6):962-968.
PMID: 37332560
PMC: 10250942.
DOI: 10.18240/ijo.2023.06.20.
miR-4529-3p Promotes the Progression of Retinoblastoma by Inhibiting RB1 Expression and Activating the ERK Signaling Pathway.
Gao Y, Du P
Mol Biotechnol. 2023; 66(1):102-111.
PMID: 37041423
DOI: 10.1007/s12033-023-00738-7.
Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?.
El Nachef L, Berthel E, Ferlazzo M, Le Reun E, Al-Choboq J, Restier-Verlet J
Cancers (Basel). 2022; 14(24).
PMID: 36551628
PMC: 9776478.
DOI: 10.3390/cancers14246141.